Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 13,435 $ 13,118
Premium and trade receivables 14,153 12,238
Short-term investments 1,794 1,539
Other current assets 3,024 1,602
Total current assets 32,406 28,497
Long-term investments 13,671 14,043
Restricted deposits 1,225 1,068
Property, software and equipment, net 2,557 3,391
Goodwill 20,310 19,771
Intangible assets, net 7,671 7,824
Other long-term assets 3,220 3,781
Total assets 81,060 78,375
Current liabilities:    
Medical claims liability 16,581 14,243
Accounts payable and accrued expenses 9,303 8,493
Return of premium payable 2,379 2,328
Unearned revenue 523 434
Current portion of long-term debt 300 267
Total current liabilities 29,086 25,765
Long-term debt 18,456 18,571
Deferred tax liability 746 1,407
Other long-term liabilities 6,209 5,610
Total liabilities 54,497 51,353
Commitments and contingencies
Redeemable noncontrolling interests 133 82
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 606,444 issued and 581,124 outstanding at June 30, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021 1 1
Additional paid-in capital 19,899 19,672
Accumulated other comprehensive earnings (loss) (913) 77
Retained earnings 8,816 8,139
Treasury stock, at cost (25,320 and 20,225 shares, respectively) (1,514) (1,094)
Total Centene stockholders’ equity 26,289 26,795
Nonredeemable noncontrolling interest 141 145
Total stockholders’ equity 26,430 26,940
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 81,060 $ 78,375